ZEISS Vision Care is excited to announce its participation in the Collaborative Community of Ophthalmic Innovation (CCOI). This global initiative is dedicated to uniting diverse stakeholders to transform groundbreaking scientific discoveries into practical solutions for eye care. The collaboration reflects ZEISS Vision Care’s unwavering commitment to advancing ophthalmic science and aligns with the company’s mission to protect and improve the vision and lifetime visual health of the world’s consumers.
Driving Innovation Through Collaboration
Padmaja Sankaridurg, Head of Myopia Innovation at ZEISS Vision Care: “Being part of the CCOI is an important step for ZEISS. Collaboration is key to driving innovation. By joining forces with other leaders in the field, including industry, regulatory bodies and academia, we aim to identify challenges and obstacles to ophthalmic innovation and use the collective power to enable and deliver cutting-edge solutions faster. Our involvement in the CCOI underscores our dedication to improving lives through pioneering ophthalmic and optical solutions.”
Owned by a foundation, ZEISS is uniquely positioned to prioritize long-term advancements in eye and vision care over short-term results. The deep-rooted commitment to innovation is further enhanced by combining the forces of ZEISS Vision Care and ZEISS Medical Technology, which provides both companies unparalleled expertise in understanding the complete needs and complexities of the human eye and vision. This synergy allows ZEISS to leverage decades of industry leadership, cutting-edge research and digital-driven technology to address the evolving needs of consumers, patients, and vision care and healthcare practioners. Joining the CCOI reflects ZEISS’ long-standing commitment to tackle the most pressing global challenges in vision and eye care.